These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 17882974)

  • 1. [How close are we from achieving the goal of eliminating pain--a channelopathy revealed the origin of pain].
    Han JS
    Sheng Li Ke Xue Jin Zhan; 2007 Jul; 38(3):199-201. PubMed ID: 17882974
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythromelalgia: a hereditary pain syndrome enters the molecular era.
    Waxman SG; Dib-Hajj SD
    Ann Neurol; 2005 Jun; 57(6):785-8. PubMed ID: 15929046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial pain syndromes from mutations of the NaV1.7 sodium channel.
    Fischer TZ; Waxman SG
    Ann N Y Acad Sci; 2010 Jan; 1184():196-207. PubMed ID: 20146699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoform-selective voltage-gated Na(+) channel modulators as next-generation analgesics.
    England S; Rawson D
    Future Med Chem; 2010 May; 2(5):775-90. PubMed ID: 21426202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future potential and status of selective sodium channel blockers for the treatment of pain.
    Priest BT
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia.
    Choi JS; Cheng X; Foster E; Leffler A; Tyrrell L; Te Morsche RH; Eastman EM; Jansen HJ; Huehne K; Nau C; Dib-Hajj SD; Drenth JP; Waxman SG
    Brain; 2010 Jun; 133(Pt 6):1823-35. PubMed ID: 20478850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazopyridines: a novel class of hNav1.7 channel blockers.
    London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in the structure-activity relationship study of small-molecule sodium channel blockers with analgesic effects].
    Li W; Zhou Y; Liu HM; You QD
    Yao Xue Xue Bao; 2009 Feb; 44(2):101-8. PubMed ID: 19408676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-gated sodium channels and pain pathways.
    Wood JN; Boorman JP; Okuse K; Baker MD
    J Neurobiol; 2004 Oct; 61(1):55-71. PubMed ID: 15362153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human pain channelopathies].
    Rugiero F
    Med Sci (Paris); 2010 Dec; 26(12):1015-7. PubMed ID: 21187031
    [No Abstract]   [Full Text] [Related]  

  • 11. Sodium channel blockers.
    Kyle DJ; Ilyin VI
    J Med Chem; 2007 May; 50(11):2583-8. PubMed ID: 17489575
    [No Abstract]   [Full Text] [Related]  

  • 12. Inherited erythermalgia: limb pain from an S4 charge-neutral Na channelopathy.
    Choi JS; Dib-Hajj SD; Waxman SG
    Neurology; 2006 Nov; 67(9):1563-7. PubMed ID: 16988069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons.
    Dib-Hajj SD; Rush AM; Cummins TR; Hisama FM; Novella S; Tyrrell L; Marshall L; Waxman SG
    Brain; 2005 Aug; 128(Pt 8):1847-54. PubMed ID: 15958509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade.
    Cheng X; Dib-Hajj SD; Tyrrell L; Waxman SG
    Mol Pain; 2008 Jan; 4():1. PubMed ID: 18171466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-gated sodium channels: therapeutic targets for pain.
    Dib-Hajj SD; Black JA; Waxman SG
    Pain Med; 2009 Oct; 10(7):1260-9. PubMed ID: 19818036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of voltage-gated sodium channels in neuropathic pain].
    Dong H; Hu SJ
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):61-3. PubMed ID: 15881349
    [No Abstract]   [Full Text] [Related]  

  • 17. Sodium channel blockers for neuropathic pain.
    Zuliani V; Rivara M; Fantini M; Costantino G
    Expert Opin Ther Pat; 2010 Jun; 20(6):755-79. PubMed ID: 20384535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation.
    Skeik N; Rooke TW; Davis MD; Davis DM; Kalsi H; Kurth I; Richardson RC
    Vasc Med; 2012 Feb; 17(1):44-9. PubMed ID: 22033523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythermalgia: molecular basis for an inherited pain syndrome.
    Waxman SG; Dib-Hajj S
    Trends Mol Med; 2005 Dec; 11(12):555-62. PubMed ID: 16278094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium channels and nociception: recent concepts and therapeutic opportunities.
    Krafte DS; Bannon AW
    Curr Opin Pharmacol; 2008 Feb; 8(1):50-6. PubMed ID: 17964852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.